Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Lineage Cell Therapeutics, Inc. < Previous 1 2 3 Next > Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to Blindness April 25, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung Cancer April 13, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage to Present at the NobleCon18 Investor Conference on April 20, 2022 April 11, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022 March 24, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss March 21, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage to Present at B. Riley Securities 2022 Virtual Oncology Conference on January 27, 2022 January 24, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX RG6501 (OpRegen®) Full Phase 1/2a Results to Be Featured at 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Allen C. Ho, M.D., FACS March 14, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference January 04, 2022 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders December 20, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen® November 30, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs November 10, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX OpRegen® Clinical Data Presented at 125th Annual American Academy of Ophthalmology Meeting by Michael S. Ip, M.D. November 15, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on November 10, 2021 November 03, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX OpRegen® Data Update to Be Featured at 2021 American Academy of Ophthalmology Annual Meeting in Presentation by Michael S. Ip, M.D. October 26, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Data From Ongoing Clinical Trial Continues to Demonstrate a Single Administration of OpRegen® Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geographic Atrophy September 15, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage to Be Featured in B. Riley Securities Fall 2021 “Growth Biotech Best Ideas” Virtual Series on October 18, 2021 October 18, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Announces Appointment of General Counsel September 01, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D. September 30, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs August 12, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D. September 13, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 August 10, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021 August 05, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX OpRegen® Clinical Data Continues to Demonstrate Functional and Anatomical Improvements in Patients With Dry AMD With Geographic Atrophy July 20, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX OpRegen® Data Update to Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D. July 13, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics Joins Russell 3000® and Russell Microcap® Indexes June 28, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testing June 22, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem® June 17, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics Announces Kevin L. Cook to Join as Chief Financial Officer June 16, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021 June 15, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX Lineage Cell Therapeutics Set to Join Russell 3000® Index and Russell Microcap® Index June 09, 2021 From Lineage Cell Therapeutics, Inc. Via Business Wire Tickers LCTX < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.